New antibodies for Long-Covid patients

CellTrend offers new antibodies for Long-Covid patients. The PAR1 (thrombin receptor) antibody as a biomarker for thrombotic events (embolism, stroke, myocardial infarction), antibodies against the chemokine receptor CXCR3 and antibodies against the scavenger protein STABILIN-1 as risk parameters for cardiac events. These 3 new biomarkers are now available on our request form!

Details

study identifies new autoantibodies as potential biomarkers for COVID-19 severity

The article about autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity is published. In this new study of 246 individuals the IgG autoantibodies against 14 different GPCRs were detected with CellTrend kits. The production of these autoantibodies is deregulated in COVID-19. Patients with moderate and severe disease have higher levels of autoantibodies than…

Details